Clinical Trials on Respiratory Viral Infection

Total 95868 results

Mark Loeb

Not yet recruiting

Fourth Dose of mRNA COVID-19 Vaccine in Residents of LTCFs

Coronavirus Infection | SARS-CoV2 Infection

Canada
Chelsea and Westminster NHS Foundation Trust

Unknown

Evaluating Clinical Parameters of COVID-19 in Pregnancy (COpregVID)

COVID-19 | COVID-19 Infection | 2019 Novel Coronavirus Infection

United Kingdom
Central Hospital, Nancy, France

Recruiting

Analysis of SARS-CoV2 Urine Viral Particles and Association With Proximal Tubular Dysfunction (CovUrinePTD)

SARS-CoV2 Infection | Proximal Tubule Dysfunction

France
University of Southern California
National Cancer Institute (NCI)

Terminated

Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19

Symptomatic COVID-19 Infection Laboratory-Confirmed

United States
University of Utah

Completed

A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure

SARS CoV-2 Infection

United States
New York University
Aliko Dangote Foundation; Nigerian Institute of Medical Research; CDC Foundation

Recruiting

The CircumVent Project: A CPAP/O2 Helmet Solution for Non-Invasive Ventilation Among Patients With COVID-19 (CircumVent)

SARS-CoV-2 Acute Respiratory Disease | COVID-19 Respiratory Infection

Nigeria
Ondine Biomedical Inc.
University of Navarra

Completed

Photodynamic Therapy for COVID-19 Prevention

SARS-CoV-2 Acute Respiratory Disease | COVID-19 Respiratory Infection

Spain
Azienda Ospedaliera di Perugia

Completed

Effects of Body Position on Diaphragmatic Activity in Patients Requiring Noninvasive Ventilation for Acute Respiratory Failure COVID-19 Related (DiaCOVIDProne)

COVID-19 Respiratory Infection | Diaphragm Injury | Noninvasive Ventlation

Italy
Beni-Suef University

Completed

Oral Symptoms of COVID-19 Among Infected Medical Doctors

COVID-19 Respiratory Infection

Egypt
Ascletis Pharmaceuticals Co., Ltd.

Not yet recruiting

Study to Evaluate Safety, Tolerability, Efficacy and Pharmacokinetics of ASC10 in Mild to Moderate COVID-19 Patients

SARS CoV 2 Infection

United States
International Vaccine Institute
Heidelberg University; International Centre for Diarrhoeal Disease Research... and other collaborators

Recruiting

Effectiveness Evaluation of the Sinopharm Vaccine in the Dondo District in Mozambique

Sars-CoV-2 Infection

Mozambique
Assistance Publique - Hôpitaux de Paris

Recruiting

LIPId Profile Changes in Inflammatory Conditions Induced by SARS-CORoronavirus-2 (LIPICOR)

SARS-CoV2 Infection

France
Beijing 302 Hospital

Not yet recruiting

A Trial of Novaferon in Asymptomatic or Mild COVID-19 Patients

SARS-CoV2 Infection
Jens D Lundgren, MD
Ministry of the Interior and Health, Denmark

Completed

A Phase IV Vaccine Study Under the National Cohort Study of Effectiveness and Safety of SARS-CoV-2 (COVID-19) Vaccines.

SARS CoV 2 Infection

Denmark
Barcelona Institute for Global Health
Hospital del Mar; Hospital Universitario Infanta Leonor; Eduardo Mondlane University and other collaborators

Active, not recruiting

SARS-CoV-2 and Acetylsalicylic Acid (SARA) (SARA)

Covid19 | SARS-CoV2 Infection

Spain, Mozambique
Hipra Scientific, S.L.U
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta; Fundación FLS... and other collaborators

Completed

A Phase III Clinical Trial to Assess Safety and Immunogenicity of a COVID-19 Vaccine Booster Dose in Immunosupressed Adults.

SARS CoV 2 Infection

Spain, Turkey
Dompé Farmaceutici S.p.A

Completed

Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.

SARS CoV 2 Infection

France, Spain, Italy
The Hospital for Sick Children

Completed

The School SPIT Study - Elementary Schools in Low COVID-19 Incidence Regions

SARS-CoV2 Infection

Canada
Collegium Medicum w Bydgoszczy

Completed

Impact of PCSK9 Inhibition on Clinical Outcome in Patients During the Inflammatory Stage of the COVID-19 (IMPACT-SIRIO 5)

Sars-CoV-2 Infection

Poland
Sona Nanotech Inc
Nova Scotia Health Authority

Completed

Clinical Evaluation of the SONA Saliva C-19 Rapid Self-Test for the Detection of COVID-19

Sars-CoV-2 Infection

Canada
IRCCS Sacro Cuore Don Calabria di Negrar

Active, not recruiting

Viral Load Analysis of the SARS-CoV-2 Virus in Nose Versus Mouth Sites

Sars-CoV-2 Infection

Italy
AIDAR Health, Inc.
MAXIS, LLC

Withdrawn

AIDI - Research & Development of a Multisensor-Based Machine Learning Technology for Real-Time Automated Detection of COVID-19 Decompensation (AIDI)

Sars-CoV-2 Infection

United States
Larissa University Hospital

Completed

Effect of Nasopharyngeal Wash With Normal Saline on SARS-CoV2 Viral Load

SARS-CoV2 Infection

Greece
Enanta Pharmaceuticals, Inc

Completed

A Study of EDP-235 in Healthy Subjects

SARS CoV 2 Infection

United States
MiCo BioMed Co., Ltd.
Syntactx

Completed

TekiTrust Tests to Determine the Level of SARS-COV-2/COVID-19 Neutralizing Antibodies in the Blood

SARS-CoV2 Infection

United States
Hôpital Universitaire Sahloul

Completed

Nigella 5 in the Treatment of SARS COV2 (COVID-19) (Nigelle5)

SARS-CoV2 Infection

Tunisia
PT Bio Farma
Sinovac Life Sciences Co., Ltd.; Faculty of Medicine Universitas Padjadjaran; National Intitute of Health Research and Development, Ministry of Health Republic of Indonesia

Completed

Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine (COVID-19)

SARS-CoV2 Infection

Indonesia
Instituto de Investigación Hospital Universitario...

Completed

Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers. (MeCOVID)

Coronavirus Infection | SARS-CoV 2 | Covid19

Spain
Assistance Publique - Hôpitaux de Paris

Unknown

Trial Evaluating Efficacy and Safety of Nivolumab (Optivo®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort. (CORIMUNO-NIVO)

COVID19- Infection With SARS-CoV-2 Virus

France
Beni-Suef University

Completed

Aerosolized Versus Intravenous Colistin-based Antimicrobial Regimens in Hospitalized COVID-19 Patients With Bacterial Coinfection: A Randomized Controlled Trial (colistin)

Secondary Bacterial Infection in COVID-19 Patients

Egypt
Imunon

Recruiting

Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2

SARS CoV 2 Infection

United States
University of Michigan
The Wallace Foundation

Recruiting

Assessing Safety of Coronavirus Infection (COVID-19) Messenger RNA (mRNA) Vaccine Administration in the Setting of a Previous Adverse Reaction

COVID-19 | Corona Virus Infection

United States
NYU Langone Health
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Understanding the Long-term Impact of COVID on Children and Families

SARS-CoV-2 Infection

United States
Cancer Institute and Hospital, Chinese Academy...
Yunnan Center for Disease Control and Prevention

Recruiting

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above

SARS-CoV2 Infection

China
University Hospital, Brest

Recruiting

Evaluation of the Sofia SARS Antigen FIA Assay for COVID-19 (ESADEC)

SARS-CoV2 Infection

France
Medical University Innsbruck
Medical University of Graz; Medical University of Vienna

Recruiting

Heterologous SARS-CoV-2 Vaccination With ChAdOx-1 and BNT162b2 (HeVacc)

SARS-CoV2 Infection

Austria
Imperial College London

Withdrawn

Recovering From COVID-19 (OVER-COVID)

SARS CoV 2 Infection
Michigan State University
Johns Hopkins University; National Cancer Institute (NCI)

Active, not recruiting

Rural Tailored COVID-19 Communication to Promote SARS-CoV-2 Antibody Testing in Saliva

SARS-CoV2 Infection

United States
University of Oklahoma
US Department of Veterans Affairs

Completed

Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment

Coronavirus Infection | Disease Prevention

United States
National Institute of Allergy and Infectious Diseases...

Completed

Surveillance of Individuals Following SARS-CoV-2 Infection

COVID-19

United States
Alvea Holdings, LLC

Completed

Safety, Tolerability and Immunogenicity of Alveavax-v1.2, a BA.2/Omicron-optimized, DNA Vaccine for COVID-19 Prevention

Sars-CoV-2 Infection

South Africa
Murdoch Childrens Research Institute
Rhinomed Pty Ltd

Completed

Diagnosis of Respiratory Viruses in Children With Rhinoswab Junior

COVID-19 | SARS CoV 2 Infection

Australia
HDT Bio
Kaiser Permanente; Rainier Clinical Research Center; C3 Research Associates

Active, not recruiting

Safety And Immunogenicity Of HDT-301 Targeting A SARS-CoV-2 Variant Spike Protein

SARS-CoV2 Infection

United States
Elsan

Completed

Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients (COVELEC)

SARS-CoV 2 | Hospitalisation-Associated Infection

France
Bharat Biotech International Limited

Completed

COVAXIN in a Pediatric Cohort (COVAXIN-Peds)

SARS-CoV2 Infection

India
Valneva Austria GmbH
National Institute for Health Research, United Kingdom

Completed

Dose Finding Study to Evaluate The Safety, Tolerability and Immunogenicity of an Inactiviated, Adjuvanted SARS-CoV-2 Virus Vaccine Candidate Against Covid-19 in Healthy Subjects

SARS-CoV-2 Virus Infection

United Kingdom
First Affiliated Hospital Xi'an Jiaotong University

Completed

Effectiveness of COVID-19 Vaccines Against the SARS-COV-2 Delta (B.1.617.2) (FASTER)

SARS CoV 2 Infection

China
Centre Hospitalier Universitaire Saint Pierre

Completed

Coronavirus Pediatric Serological Study (CoPSS)

SARS-CoV2 Infection

Belgium
Schön Klinik Berchtesgadener Land

Completed

Automatic Oxygen Titration in Patients After SARS-CoV-2 Infection

Post-COVID19

Germany
National Polytechnic Institute, Mexico

Unknown

Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T) (FUTURE-T)

COVID-19 | SARS-CoV-2 Infection

Mexico

Clinical Trials on Respiratory Viral Infection

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations